Overview

Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study is aimed to examine the possible interactions of sublingual and intravenous buprenorphine with rifampicin.
Phase:
Phase 4
Details
Lead Sponsor:
Turku University Hospital
Treatments:
Buprenorphine
Rifampin